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Summary. Background: Fibrin plays a crucial role in haemostasis and wound healing by forming strain-stiffening fibrous networks that reinforce blood clots. The molecular origin of fibrin's strain-stiffening behavior remains poorly understood, primarily because plasma fibrinogen is a complex mixture of heterogeneous molecular variants and is often contaminated by plasma factors that affect clot properties. Objectives and methods: To facilitate mechanistic dissection of fibrin nonlinear elasticity, we produced a homogeneous recombinant fibrinogen corresponding to the main variant in human plasma, termed rFib610. We characterized the structure of rFib610 clots using turbidimetry, microscopy and X-ray scattering. We used rheology to measure the strain-stiffening behavior of the clots and determined the fiber properties by modeling the clots as semi-flexible polymer networks. Results: We show that addition of FXIII to rFib610 clots causes a dose-dependent stiffness increase at small deformations and renders the strain-stiffening response reversible. We find that c-chain cross-linking contributes to clot elasticity by changing the force-extension behavior of the protofibrils, whereas a-chain cross-linking stiffens the fibers, as a consequence of tighter coupling between the constituent protofibrils. Interestingly, rFib610 protofibrils have a 25% larger bending rigidity than plasma-purified fibrin protofibrils and a delayed strain-stiffening, indicating that molecular heterogeneity influences clot mechanics at the protofibril scale. Conclusions: Fibrinogen molecular heterogeneity and FXIII affect the mechanical function of fibrin clots by altering the nonlinear viscoelastic properties at the protofibril and fiber scale. This work provides
Introduction
Fibrinogen is a fibrous protein that assembles into an elastic fibrin network upon vascular injury [1] . Biophysical studies have shown that fibrin networks can stiffen up to 1000-fold when sheared or stretched [2, 3] and the constituent fibers can be stretched up to 4-fold their original length without breaking [4] . These extraordinary nonlinear elastic properties appear to be crucial for clot function, because mutations in fibrinogen or its regulatory factors that affect fibrin mechanics are associated with severe clotting disorders [5] .
The structural origin of fibrin's nonlinear elastic behavior has been difficult to elucidate because of fibrin's complex hierarchical structure. Fibrinogen monomers, which are built from two sets of Aa, Bb and c chains, assemble into double-stranded protofibrils by non-covalent interactions [6] , and these bundle into fibers that branch and percolate to form space-spanning networks (Figs. 1A,  2A ). The key challenge is therefore to separate contributions from the molecular, protofibril, fiber and network scales to fibrin clot mechanics. This challenge has been partly met by characterizing individual fibrin fibers and molecules. Tensile tests on single fibers revealed that their extensibility [7, 8] and elasticity [9] are correlated with the length of aC connectors, suggesting that the elastomeric behavior of fibrin clots originates from the composite structure of the fibers, with rigid, folded domains interconnected by flexible linkers [10] . However, force spectroscopy [11, 12] and molecular simulations [13] of fibrin molecules showed that forced unfolding of the coiled-coil domains and the c chains can also contribute. Further, fibrin's mechanical properties in vivo crucially depend on the presence of factor XIII (FXIII), which catalyzes covalent cross-linking between monomers [14] . Cross-linking increases the stiffness of fibrin networks [15] [16] [17] and prevents irreversible deformation of the fibers [18] . Because FXIII forms c-chain cross-links within protofibrils as well as a-chain cross-links between protofibrils [19] , it probably changes both the properties of the protofibrils and the interactions between them.
An important obstacle in tracing fibrin clot mechanics down to the molecular scale is that fibrinogen purified from human plasma, used in most studies, has a heterogeneous molecular composition arising from partial proteolytic degradation of the Aa chains, resulting in three main fibrinogen variants [20] [21] [22] and alternative splice variants [23, 24] . These variants result in clots with marked differences in fiber diameter and network structure [22, 25, 26] . Purified plasma fibrinogen furthermore often contains variable amounts of other plasma proteins such as FXIII and fibronectin [27] .
To provide a more controllable experimental system, following the pioneering work of Gorkun et al. [28] , we here report the production and characterization of recombinant human fibrinogen having intact Aa chains with 610 amino acids, corresponding to the main constituent of plasma fibrinogen. We for the first time produce the recombinant protein, termed rFib610, at a scale large enough to allow systematic study of the nonlinear viscoelasticity of reconstituted clots, thus complementing previous studies that focused on the linear (micro)rheology of recombinant fibrin networks [29] and the mechanics of single fibers [10, 18] . We demonstrate that FXIII-mediated c-and a-chain cross-linking differentially act at the protofibril and fiber levels to stiffen fibrin clots and suppress plastic deformation. Additionally, we uncover the influence of molecular heterogeneity on the force-extension behavior of individual protofibrils. 
Material and methods
Recombinant fibrinogen production cDNAs for the individual fibrinogen chains were cloned in separate pcDNA3.1(+) expression vectors. The Aa-chain cDNA (629 residues), Bb-chain cDNA (491 residues) and c-chain cDNA (437 residues, isoform cA) resulted in the production of mature Aa, Bb and c chains as found in circulation (610, 461 and 411 residues, respectively). rFib610 was produced in PER.C6 Ò cells using a fed-batch procedure in a stirred-tank reactor with CDM4PERMAb/PERMAab feed, as described previously for IgM [30] . During the expansion period, the culture supernatants were screened for fibrinogen with intact Aa chains [31] , with plasma-derived fibrinogen (pFib) from Enzyme Research Laboratories (ERL, Swansea, UK) as reference. Recombinant fibrinogen (rFib610) was purified from the clarified cell-culture medium using cationic and anionic column chromatography (details are not disclosed for proprietary reasons) and was concentrated to 15-25 mg mL À1 in PBS by diafiltration [32] , with a typical yield of 0.3-0.4 g L À1 of cell culture supernatant. Both rFib610 and pFib were dialyzed into HBS buffer (20 mM HEPES, 150 mM NaCl, pH 7.4) against 1009 sample volume. The final protein concentration was measured by spectrophotometry and confirmed by total protein measurements with a modified Biuret method using the Pierce BCA Protein Assay kit (Thermo Fisher Scientific, Landsmeer, the Netherlands). Glycosylation and gel filtration analyses reveal similar extents of N-linked glycosylation and a small (6-9%) fraction of oligomers in rFib610 and pFib (Figs. S1, S2).
Fibrinogen molecular composition, fibrin formation and cross-linking Fibrin clots were obtained by adding 1 U mL À1 human a-thrombin (ERL) to fibrinogen in HBS buffer supplemented with 2 mM CaCl 2 and incubating for 4 h at 37°C unless indicated otherwise. To access the response of fibrin protofibrils, we also assembled clots under fine clot buffer conditions (50 mM Tris-HCl, pH 8.5, 400 mM NaCl) [33] in the presence of 3.2 mM CaCl 2 and 0.5 U mL À1 thrombin at 37°C for 4 h. The molecular composition and degree of cross-linking of the samples were evaluated by sodium-dodecyl-sulfate polyacrylamide-gel-electrophoresis (SDS-PAGE) on 8% gels. Cross-linked rFib610 clots were obtained by adding purified human FXIII zymogen (ERL) to the assembly solution containing thrombin and calcium. We used reversed-phase high-performance liquid chromatography (RP-HPLC) to analyze fibrinopeptide release upon thrombin activation [34] .
Multi-scale structural characterization
We characterized the network structure of fibrin clots by imaging clots with a confocal laser scanning microscope (Nikon Eclipse Ti, Amsterdam, the Netherlands) using a 488-nm laser (Coherent Inc., Utrecht, the Netherlands) for illumination and photomultiplier tube detector. The clots were fluorescently labeled by co-polymerizing fibrinogen with 10 mole% Oregon-Green-488-labeled fibrinogen (Invitrogen, Bleiswijk, the Netherlands). Three-dimensional z-stack images were obtained with a 1009 oilimmersion objective (numerical aperture = 1.49). The network structure was examined in higher resolution by scanning electron microscopy (SEM; Zeiss Supra 25, Thornwood, NY, USA; Fig. S3 ). We characterized fibrin fiber structure by turbidity measurements using a UV1 Spectrophotometer Thermo Fisher Scientific). We computed the average diameter, d, and mass/length ratio, l, of the fibers from the data using a theoretical model for light scattering from isotropic networks of rigid rod-like particles [15, 35, 36] , with correction for wavelength dispersion [37] (see Fig. S4 ). The samples were polymerized for 4 h in humid 37°C conditions in cuvettes (Plastibrand UV-cuvette micro, Sigma Aldrich, Zwijndrecht, the Netherlands) with an optical path length of 1 cm. The early-stage kinetics of fibrin polymerization was monitored using an Ultrospec 2100 Pro (Amersham Biosciences, Valley Stream, NY, USA) spectrophotometer. Comparative tests with colloidal samples and different optical path lengths confirmed that multiple scattering was negligible in our measurements.
The axial molecular packing order of the fibrin fibers was examined by small-angle X-ray scattering (SAXS) measurements at the DUBBLE beamline of the European Synchrotron Radiation Facility (ESRF, Grenoble, France) on fibrin samples polymerized in 2-mm diameter glass capillaries (Hilgenberg, Malsfeld, Germany). The incoming X-ray beam (12 keV) was focused to a 300 9 350-lm spot and scattering patterns were collected with 1-min exposure at room temperature using a Pilatus 1M detector (Dectris, Baden, Switzerland) at a sample-todetector distance of 2.8 m. The patterns were background-corrected for the glass capillary and buffer and radially-averaged to obtain scattering curves of intensity I as a function of wavevector q. The q-range was calibrated using silver behenate powder as reference.
Rheology
Fibrin samples were polymerized in situ in the steel coneplate geometry (40 mm diameter, 1°cone angle) of a rheometer (Physica MCR 501; Anton Paar, Graz, Austria) preheated to 37°C. The linear shear moduli of fullyformed clots were measured by applying 0.5% oscillatory strain at a frequency of 0.5 Hz. To quantify the nonlinear response, we utilized differential measurements [38] : the sample was held at constant stress, s, and the differential strain response, dc, to a superposed stress oscillation of amplitude |ds| = 0.1s was measured. To test the elastic limits of the samples, we performed (i) consecutive differential measurements by iteratively increasing the prestress s to a maximum value s m and releasing it and (ii) consecutive creep tests by monitoring the strain, c, in response to a constant stress for 60 s followed by stress release.
Results

Compositional and structural characterization of rFib610 fibrin
We first validate the homogeneous composition of rFib610 fibrinogen using SDS-PAGE. As expected, we observe three bands corresponding to the Aa (66 kDa), Bb (52 kDa) and c (47 kDa) chains (Fig. 1B) . Addition of thrombin causes a slight shift of the Aa-and Bbchain bands towards lower MW, indicating successful cleavage of FpA and FpB. A weak band also appears below the main a-chain band, indicating a small degree of proteolytic degradation [28] . There are no high MW bands, proving the absence of FXIII. In contrast, fibrin prepared by thrombin activation of plasma fibrinogen (pFib) displays clear high MW bands originating from covalently cross-linked a-chain polymers and c-dimers [39, 40] and two minor bands that are absent in rFib610.
Next, we analyzed the fibrinopeptides released from the fibrinogen E-region using RP-HPLC. The HPLC profile of rFib610 (Fig. 1C , red trace) shows the main FpA and FpB peaks at retention times of 38 and 55 min, respectively, and a minor FpB desArg peak eluting at 48 min. These peaks are identical to those found with pFib (Fig. 1C , black trace) [41] . However, rFib610 is free of the two FpAP and FpAY minor peaks commonly seen with pFib [34] . Thus, rFib610 possesses a high degree of molecular homogeneity, in contrast to the heterogeneity of pFib. Kinetic analysis of fibrinopeptide release shows a fast release of FpA followed by slower release of FpB (Fig. S5A) , consistent with prior reports on plasmaderived fibrinogen [42, 43] . FpA release allows for the formation of double-stranded protofibrils, followed by non-covalent protofibril bundling into thicker fibers facilitated by aC connectors that dissociate from the fibrinogen E-region upon release of FpB [44, 45] . Indeed, upon thrombin addition the turbidity of rFib610 quickly rises (Fig. S5B) , reflecting the bundling of protofibrils into thick fibers that strongly scatter light.
We then performed a multi-scale structural analysis of rFib610 clots over a range of concentrations, from 0.8 to 5 mg mL
À1
, spanning the physiological levels of fibrinogen in plasma (2-4 mg mL
). At the network scale, confocal microscopy and SEM show homogeneous, isotropic networks (Figs. 2B, S3 ). The average pore diameter determined from analysis of the confocal images monotonically decreases with increasing fibrin concentration, from 4.7 AE 0.4 lm at 0.8 mg mL À1 to 1.5 AE 0.2 lm at 5 mg mL À1 (Fig. S6 ). This 3.1-fold reduction is larger than the 2.5-fold reduction expected from the inverse-square-root dependence of pore size on concentration if concentration only affects the fiber number density [46] , suggesting increased protofibril lateral association with increasing fibrin concentration, perhaps because of the changing thrombin/fibrinogen ratio. This hypothesis is supported by turbidity measurements of the average fiber mass/length ratio, l (Fig. 2E) . Given a protofibril l = 1.44 9 10 4 Da nm À1 [47] , the average number of protofibrils within each fiber, N p , can be calculated to increase from 60 at 0.8 mg mL À1 to 95 at 5 mg mL À1 , accompanied by an increase of fiber diameter from 130 to 180 nm (Fig. 2D) . At the molecular scale, SAXS measurements show that rFib610 fibers exhibit a peak at q~0.85 nm À1 that corresponds to the third-order reflection of the axial repeat distance of 22.5 nm (Figs. 2A ,C, S7) [2] . Thus, rFib610 fibers possess the same half-staggered molecular packing order as pFib fibers.
Nonlinear rheology of uncross-linked rFib610 clots
The purity of rFib610 preparation makes it an ideal model system to study the rheological behavior of fibrin clots in the strict absence of FXIII-mediated cross-linking, providing a more stringent benchmark than that obtainable for plasma-derived fibrinogen that requires FXIII removal [48, 49] or inhibition [15, [50] [51] [52] . We first characterized the viscoelastic response of uncross-linked rFib610 clots at small deformations. The elastic modulus G 0 is nearly independent of frequency and the ratio between the viscous and elastic moduli, tan d = G″/G 0 , is much less than 1 for all fibrin concentrations studied (Fig. 3A) . The linear modulus G 0 strongly increases with increasing fibrin concentration, from 10 Pa at 0.8 mg mL À1 to 500 Pa at 5 mg mL À1 (Fig. 3B) , whereas tan d decreases from 0.10 to 0.02, indicating suppression of viscous dissipation (Fig. 3C) . Thus rFib610 clots behave like elastic solids despite the absence of covalent cross-links. The non-covalent interactions responsible for fibrin self-assembly, with measured binding energies of 20-50 k B T per molecule [11, 45, [53] [54] [55] , are therefore sufficient to provide an elastic response at small deformations.
To test the response of rFib610 clots to large deformations, we applied increasing levels of shear stress and measured the change in the differential elastic, K 0 , and viscous, K″, moduli. Both moduli strongly increase as stress is ramped up (Fig. 3D ). This response is reversible up to strains of~50%, whereas beyond that the clots become softer with each repeated loading (Fig. 3E) . Moreover, the clots exhibit creep and incomplete strain recovery when stress is removed (Fig. 3F) . The non-covalent interactions are therefore not sufficiently strong to prevent irreversible (viscoplastic) changes at large deformations. This finding is consistent with conclusions from recent studies of plasma fibrin clots, which showed that FXIII removal caused irreversible behavior at large stresses [49, 52] .
The effect of FXIII-mediated cross-linking
The absence of FXIII in rFib610 is also ideal for testing how controllable levels of FXIII-mediated cross-linking (Fig. 4A ) affect fibrin rheology, providing a more precise approach than chemical-or antibody-mediated FXIII inhibition used in previous studies of plasma fibrinogen [15, 40, 48, 51, 52] . SDS-PAGE analysis shows that when we add 5 lg mL À1 FXIII to 2 mg mL À1 rFib610, the c chains fully dimerize, stabilizing the protofibrils, whereas the a chains connecting adjacent protofibrils are < 60% cross-linked (Fig. 4C-D) . Increasing FXIII concentration leads to increasing multimerization of a chains until complete a-chain cross-linking with 20 lg mL À1 (or 40 Loewy U mL
À1
) FXIII. Confocal and SEM imaging show no obvious effect of FXIII on rFib610 network structure (Figs. 4B, S3) , consistent with recent reports on plasma fibrin [15, 48] . Indeed, turbidimetry reveals that cross-linking results in only a slight decrease of fiber diameter (Fig. S8) .
Rheology measurements show that FXIII-mediated cross-linking strongly enhances clot stiffness at small deformations: G 0 progressively increases from 90 Pa for 2 mg mL uncross-linked rFib610 to 150 Pa at 5 lg mL À1 and 560 Pa at 20 lg mL À1 FXIII (Fig. 4E ).
In contrast, viscous dissipation, as measured by tan d, immediately drops from 0.045 to 0.016 upon addition of 5 lg mL À1 FXIII and is not further reduced with higher FXIII (Fig. 4F) . These results suggest that viscous dissipation in fibrin clots is mainly determined by c-chain cross-linking, which controls molecular connectivity within protofibrils, whereas clot stiffness is determined by a combination of c-chain cross-linking within protofibrils and multimeric a-chain cross-linking between protofibrils, which acts at the fiber level. At large stresses, we find similar strain-stiffening behavior in both cross-linked and uncross-linked rFib610 clots (Fig. 4G) . Strikingly, cross-linking leads to a completely reversible response up to~200% strains (close to breakage) in the presence of only 5 lg mL À1 FXIII, even though a-chain cross-linking is incomplete at this FXIII level. Moreover, cross-linking suppresses creep during stress application and incomplete strain recovery after stress removal (Fig. S9 ).
Structural basis of fibrin nonlinear rheology
Both uncross-linked and cross-linked rFib610 clots show a triphasic strain-stiffening response (Fig. 5A,B) , similar to that observed for plasma fibrin [50, 56] . The first (linear) regime corresponds to entropic elasticity associated with the resistance of the fibers to straighten out their thermal bending fluctuations, as validated previously by optical tweezer microrheology [56] . This entropic regime vanishes when the fibers are thicker or at high fibrin concentration [57, 58] . Once the fibers are straightened, the network stiffness increases (regime 2) until the stress is large enough to axially stretch the fiber backbone (regime 3). Prior studies on plasma fibrin clots showed excellent agreement of the fiber mechanical properties inferred from the triphasic strain-stiffening response [50, 56, 57] and from light-scattering and single-fiber experiments [3, 10, 18, 59] . Below we will use the same theoretical framework to interrogate rFib610 fibrin mechanics. Fiber bending rigidity is typically quantified by the persistence length, which represents the length over which the filament deviates from a straight conformation. By modeling fibrin fiber as a semi-flexible bundle of N p protofibrils, each having a persistence length, l p , we can estimate its effective persistence length as l p N x p [60] . The factor x quantifies the strength of coupling between the protofibrils, which should depend on the extent of a-chain cross-linking between protofibrils and vary between 1 for loose coupling and 2 for tight coupling. Entropic elasticity models predict that the linear modulus of the network (regime 1), G 0 , is directly related to l p and N p via [50] :
Here k B T is the thermal energy and q = c/l denotes fiber contour length density, where c is fibrin concentration. Knowing G 0 from rheology and N p from turbidimetry, we can therefore use Eq. (1) to infer the strength of protofibril bundling within rFib610 fibers, provided l p is known. We estimated l p by fitting measured strain-stiffening curves for fine fibrin clots, which show suppressed protofibril bundling (Figs. S10, S11), to the theoretical prediction of entropic stiffening of semi-flexible filament networks [56] ( Fig. S12 ). Assuming N p = 2 (based on turbidimetry data) and x = 1, as in plasma fine clots [50] , we infer l p of rFib610 protofibrils to be 75 nm. Using this l p value, we find that x for (bundled) rFib610 clots varies between 1.90 AE 0.22 in the absence of FXIII and 2.25 AE 0.15 with 20 lg mL À1 FXIII (Fig. 5C ). The latter value exceeds the tight coupling limit (x = 2), probably because of the uncertainty in l p , as electron microscopy imaging shows that N p varies between 1 and 2 within the network (Fig. S11) . Similar analysis assuming other l p estimates consistently yields a similar trend of increasing x with increasing FXIII concentration (Fig. S13) . FXIII-mediated a-chain cross-linking therefore increases clot stiffness by strengthening protofibril associations and stiffening the fibers.
To extract the force-extension behavior of the fibers, we consider the strain-stiffening behavior in regime 3 and rescale the stress-stiffening curves by the protofibril length density, N p q. The curves for uncross-linked and crosslinked rFib610 clots overlap in regime 3 (Fig. 5F , blue symbols), indicating that the protofibrils contribute independently to network elasticity. The scaled curves initially show a plateau, from which we can infer the linear stretch rigidity of the protofibrils (Table 1) , followed by a strainstiffening regime (Fig. 5B) . The fibers themselves apparently stiffen when they are sufficiently stretched, consistent with AFM studies on single plasma fibrin fibers that demonstrated strain-stiffening above strains of 100% [10, 61] . Interestingly, cross-linked rFib610 fibers show more pronounced stiffening (~2-fold larger slope) than their uncross-linked counterparts once the average force per protofibril s/(N p q) exceeds~1 pN, suggesting that cross-linking changes the force-extension behavior of the fibers. To distinguish the roles of c-and a-chain crosslinking in this fiber stiffening, we analyzed the nonlinear behavior of rFib610 fine clots where cross-linking occurs primarily through c-chains (Fig. S10) . Clots of crosslinked rFib610 protofibrils stiffen in a similar manner to bundled rFib610 clots (Fig. 5D-E, triangles) . Surprisingly, uncross-linked rFib610 protofibrils (Fig. 5E, circles) show an extended stiffness plateau that remains constant until the average force per protofibril reaches~4 pN (Fig. 5F ). This is in contrast to both cross-linked protofibrils and fibers, which already stiffen at~1 pN. From the network stiffness at this plateau, we estimate the stretch modulus of the protofibrils to be~100 pN, similar to previously reported values of 50-100 pN for fish fibrin protofibrils [3] . We finally test the role of molecular composition in protofibril mechanics by comparing fine rFib610 clots with their pFib counterparts. At low stress, fine rFib610 clots are always stiffer than fine pFib, regardless of cross-linking (Fig. S14) . Using the polymer elasticity model explained above, we infer that rFib610 protofibrils have a 25% larger bending rigidity than pFib protofibrils (Table 1 and Fig. S15 ). Moreover, cross-linking increases the stretch modulus of rFib610 protofibrils by 50% (Table 1) , whereas it does not affect the stretch modulus of pFib protofibrils [50] . Thus, molecular heterogeneity directly affects the mechanical properties of fibrin protofibrils. 
Discussion
Understanding the molecular basis of fibrin elasticity is a long-standing challenge that is difficult to address because of fibrin's multi-scale structure and molecular heterogeneity. We here show that recombinant fibrinogen provides an ideal model system to systematically probe the role of molecular composition and plasma factors in clot mechanics.
Our results show that the viscoelasticity of fibrin clots is determined by intermolecular cross-links both within and between protofibrils. At low strain, the influence of a-chain cross-linking on the stiffness of fibrin clots [15, 17, 62] and fibers [10, 18, 61] can be explained by strengthening of protofibril association within each fiber. At high strain, where the network response is dominated by the force-extension behavior of individual fibers, we observe nonlinearity regardless of protofibril bundling, suggesting a much more limited role of a-chain cross-linking in fiber stretching. Because the protofibrils are stretched independently at high axial loads [63] , forced unfolding of the constituent monomers is likely to be the main source of the intrinsic nonlinearity of protofibril (and fiber) stretching [8, 64] . Interestingly, protofibrils have been proposed to undergo hyperbranching within fibers [65] , which may potentially modify the fiber forceextension response. Further investigation into the secondary structure and monomer packing within strained fibers is necessary to precisely resolve this regime.
Our results also indicate that c-chain cross-linking contributes to clot viscoelasticity by rendering the network response more reversible and by directly changing the force-extension behavior of protofibrils. These findings significantly expand our understanding of the elusive role of c-chain cross-linking in fibrin mechanics [17, 51, 62, 66] . The structural origin of the reduced onset force for stretch-stiffening from 4 to 1 pN for uncross-linked rFib610 protofibrils remains unknown. This force level is much lower than the critical forces required to unfold fibrinogen's coiled-coil region (125 pN) or c nodule (74 pN), but could be related to entropic stretching of aC connectors [9] , suggesting an entropic origin of protofibril strain-stiffening. Subtle changes in intermolecular connectivity, for instance as a result of hyperbranching [65] , may potentially shift the onset of unfolding of the different domains of fibrin molecules within the protofibrils. Our data therefore establish that c-chain and a-chain crosslinking have distinct effects on the linear viscoelasticity of fibrin clots as well as the strain-stiffening response at the network, fiber and protofibril levels.
Despite the difference in molecular composition and probably also in post-translational modifications, rFib610 displays similar early kinetics of thrombin-mediated fibrinopeptide release, protofibril formation and bundling as pFib, resulting in a similar clot and fiber structure. However, the nonlinear rheological response of uncross-linked rFib610 protofibrils shows a larger bending rigidity and an extended linear response compared with pFib protofibrils. These observations suggest that molecular composition influences fiber and network mechanics by modulating properties at the protofibril scale. At the fiber level, changes in molecular composition can potentially influence the lateral packing of protofibrils within the fibers, which has been recently linked to fibrin fiber stiffness [67] and cell mechanosensing [68] . It will be interesting to probe the effect of molecular and structural heterogeneity on protofibril and fiber stiffness directly by AFM-based nanoindentation and pulling [10, 61] . These experiments can also help in independently quantifying protofibril persistence length. Here we report l p = 75 nm, which is smaller than l p values predicted by modeling protofibrils as homogeneous elastic rods [3, 65, 69] . However, recent atomistic molecular dynamics simulations point to the existence of hinge points within fibrinogen coiled-coil regions [70] and in the D : D interface between fibrin monomers within single-stranded oligomers [71] that may make protofibrils more flexible than anticipated.
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